Matrix metalloproteinase-9 in cerebral aneurysms

Neurosurgery

Volumn 41, Issue 3, 1997, Pages 642-647

  Kim, Samuel C ^a   Singh, Meharvan ^a   Huang, Judy ^a   Prestigiacomo, Charles J ^a   Winfree, Christopher J ^a   Solomon, Robert A ^a   Connolly Jr , E Sander ^a,b  

^a College of Physicians and Surgeons ^*  (United States)

^b Box 72 ^*  (United States)

Author keywords

Aneurysm; Artery; Intracranial; Matrix metalloproteinase 9; Superficial temporal artery; Tissue inhibitor of metalloproteinase

Indexed keywords

GELATINASE; GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE;

ANEURYSM CLIP; ARTICLE; BRAIN ARTERY ANEURYSM; CLINICAL ARTICLE; CONTROLLED STUDY; CRANIOTOMY; DISEASE COURSE; ENZYME ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; PATHOGENESIS; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; RISK FACTOR; SUPERFICIAL TEMPORAL ARTERY;

ANEURYSM, RUPTURED; BIOLOGICAL MARKERS; CEREBRAL ARTERIES; COHORT STUDIES; COLLAGENASES; CRANIOTOMY; HUMANS; INTRACRANIAL ANEURYSM; MATRIX METALLOPROTEINASE 9; REFERENCE VALUES; TEMPORAL ARTERIES; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 0030824379     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-199709000-00027     Document Type: Article

References (24)

1. Allen PI: Screening for abdominal aortic aneurysm. Biomed Pharmacother 42:451-454, 1988.
2. Baker T, Tickle S, Wasan H, Docherty A, Isenberg D, Waxman J: Serum metalloproteinases and their inhibitors: Markers for malignant potential. Br J Cancer 70:506-512, 1994.
3. Baricos W, Murphy G, Zhou YW, Nguyen HH, Shah SV: Degradation of glomerular basement membrane by purified mammalian metalloproteinases. Biochem J 254:609-612, 1988.
4. Brophy CM, Marks WH, Reilly JM, Tilson MD: Decreased tissue inhibitor of metalloproteinases (TIMP) in abdominal aortic aneurysm tissue: A preliminary report. J Surg Res 50:653-657, 1991.
5. Carmichael DF, Stricklin GP, Stuart JM: Systemic administration of TIMP in the treatment of collagen-induced arthritis in mice. Agents Actions 27:378-379, 1989.
6. Freestone T, Turner RJ, Coady A, Higman DJ, Greenhalgh RM, Powell JT: Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 15:1145-1151, 1995.
7. Gordon JL, Drummond WA, Galloway WA: Metalloproteinase inhibitors as therapeutics. Clin Exp Rheumatol 11[Suppl 8]:S91-S94, 1993.
8. Jean-Claude J, Newman KM, Hong L, Gregory AK, Tilson MD: Possible key role for plasmin in the pathogenesis of abdominal aortic aneurysms. Surgery 116:472-478, 1994.
9. Juvela S: Prevalence of risk factors in spontaneous intracerebral hemorrhage and aneurysmal subarachnoid hemorrhage. Arch Neurol 53:734-740, 1996.
10. Kosierkiewicz T, Murali R, Hirschfield A: Expression of matrix metalloproteinase-1 by smooth muscle cells in human cerebral berry aneurysms. 64th Annual Meeting, American Association of Neurological Surgeons, Minneapolis. 1996 (poster).
11. Krupski WC: The peripheral vascular consequences of smoking. Ann Vasc Surg 5:291-304, 1991.
12. Louwrens HD, Kwaan HC, Pearce WH, Yao JS, Verrusio E: Plasminogen activator and plasminogen activator inhibitor expression by normal and aneurysmal human aortic smooth muscle cells in culture. Eur J Vasc Endovasc Surg 10:289-293, 1995.
13. Matrisian LM: Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 6:121-125, 1990.
14. Morodomi T, Ogata Y, Sasaguri Y, Morimatsu M, Nagase H: Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukaemia and HT1080 fibrosarcoma cells. Biochem J 285:603-611, 1992.
15. Murphy G, Ward R, Gavrilovic J, Atkinson S: Physiological mechanisms for metalloproteinase activation. Matrix Suppl 1:224-230, 1992.
16. Newman KM, Jean-Claude J, Li H, Scholes JV, Ogata Y, Nagase H, Tilson MD: Cellular localization of matrix metalloproteinases in the abdominal aortic aneurysm wall. J Vasc Surg 20:814-820, 1994.
17. Newman KM, Malon AM, Shin RD, Scholes JV, Ramey WG, Tilson MD: Matrix metalloproteinases in abdominal aortic aneurysm: Characterization, purification, and their possible sources. Connect Tissue Res 30:265-276, 1994.
18. Newman KM, Ogata Y, Malon AM, Irizarry E, Gandhi RH, Nagase H, Tilson MD: Identification of matrix metalloproteinases 3 (stromelysin-1) and 9 (gelatinase B) in abdominal aortic aneurysm. Arterioscler Thromb 14:1315-1320, 1994.
19. Okada Y, Naoto T, Tomita K, Nakanishi I, Nagase H: Immunolocalisation of matrix metalloproteinase 3 (stromelysin) in rheumatoid synovioblasts (B cells): Correlation with rheumatoid arthritis. Ann Rheum Dis 48:645-653, 1989.
20. Salo T, Makela M, Kylmaniemi M, Autio-Harmainen H, Larjava H: Expression of matrix metalloproteinase-9 during early human wound healing. Lab Invest 70:176-182, 1994.
21. Schlote W, Gaus C: Histological aspects from ruptured and nonruptured aneurysms. Neurol Res 16:59-62, 1994.
22. Sterpetti AV, Cavallaro A, Cavallari N, Allegrucci P, Tamburelli A, Agosta F, Bartoli S: Factors influencing the rupture of abdominal aortic aneurysms. Surg Gynecol Obstet 173:175-178, 1991.
23. Vine N, Powell JT: Metalloproteinases in degenerative aortic disease. Clin Sci 81:233-239, 1991.
24. Willenbrock F, Murphy G: Structure-function relationships in the tissue inhibitors of metalloproteinases. Am J Respir Crit Care Med 150[Suppl]:S165-S170, 1994.